The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: A prospective survey of 202 cases in Japan

Tomonori Hidaka, Kotaro Shide, Haruko Shimoda, Takurou Kameda, Keiko Toyama, Keiko Katayose, Youko Kubuki, Kenji Nagata, Katsuto Takenaka, Koichi Akashi, Takashi Okamura, Yoshiyuki Niho, Hideaki Mizoguchi, Mitsuhiro Omine, Keiya Ozawa, Mine Harada, Kazuya Shimoda

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Cytogenetic abnormalities were often observed in primary myelofibrosis patients. The presence of specific cytogenetic abnormalities, such as sole abnormalities of chromosome 13q-, 20q-, or -7/7q-, is reported to have the influence on the prognosis of primary myelofibrosis. We analyzed the data from the prospective survey of Japanese primary myelofibrosis patients which was conducted from 1999 to clarify the impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis. A total of 202 primary myelofibrosis patients had the cytogenetic and the prognostic data. Eighty (40%) out of 202 cases had cytogenetic abnormalities, and an association was evident for platelet counts. Although the presence of an abnormal karyotype did not affect the prognosis, primary myelofibrosis patients with cytogenetic abnormalities other than 13q- and 20q- showed an inferior prognosis compared to patients with a normal karyotype or sole 13q- or 20q- abnormalities. Patients with an unfavorable cytogenetic profile (abnormal cytogenetics other than 13q- or 20q-) also had a greater tendency to transform to leukemia than patients with a favorable cytogenetic profile (normal cytogenetics, sole abnormalities of either chromosome 13q-, or 20q-). Abnormal cytogenetics other than 13q- or 20q- in primary myelofibrosis patients has the poor prognostic effect for both survival and the risk of leukemic transformation.

Original languageEnglish
Pages (from-to)328-333
Number of pages6
JournalEuropean Journal of Haematology
Volume83
Issue number4
DOIs
Publication statusPublished - Oct 1 2009

Fingerprint

Primary Myelofibrosis
Chromosome Aberrations
Japan
Cytogenetics
Abnormal Karyotype
Surveys and Questionnaires
Platelet Count
Karyotype
Leukemia
Chromosomes
Survival

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis : A prospective survey of 202 cases in Japan. / Hidaka, Tomonori; Shide, Kotaro; Shimoda, Haruko; Kameda, Takurou; Toyama, Keiko; Katayose, Keiko; Kubuki, Youko; Nagata, Kenji; Takenaka, Katsuto; Akashi, Koichi; Okamura, Takashi; Niho, Yoshiyuki; Mizoguchi, Hideaki; Omine, Mitsuhiro; Ozawa, Keiya; Harada, Mine; Shimoda, Kazuya.

In: European Journal of Haematology, Vol. 83, No. 4, 01.10.2009, p. 328-333.

Research output: Contribution to journalArticle

Hidaka, T, Shide, K, Shimoda, H, Kameda, T, Toyama, K, Katayose, K, Kubuki, Y, Nagata, K, Takenaka, K, Akashi, K, Okamura, T, Niho, Y, Mizoguchi, H, Omine, M, Ozawa, K, Harada, M & Shimoda, K 2009, 'The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: A prospective survey of 202 cases in Japan', European Journal of Haematology, vol. 83, no. 4, pp. 328-333. https://doi.org/10.1111/j.1600-0609.2009.01298.x
Hidaka, Tomonori ; Shide, Kotaro ; Shimoda, Haruko ; Kameda, Takurou ; Toyama, Keiko ; Katayose, Keiko ; Kubuki, Youko ; Nagata, Kenji ; Takenaka, Katsuto ; Akashi, Koichi ; Okamura, Takashi ; Niho, Yoshiyuki ; Mizoguchi, Hideaki ; Omine, Mitsuhiro ; Ozawa, Keiya ; Harada, Mine ; Shimoda, Kazuya. / The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis : A prospective survey of 202 cases in Japan. In: European Journal of Haematology. 2009 ; Vol. 83, No. 4. pp. 328-333.
@article{cad2e7c5000143e2b41a31cbe4fb250f,
title = "The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: A prospective survey of 202 cases in Japan",
abstract = "Cytogenetic abnormalities were often observed in primary myelofibrosis patients. The presence of specific cytogenetic abnormalities, such as sole abnormalities of chromosome 13q-, 20q-, or -7/7q-, is reported to have the influence on the prognosis of primary myelofibrosis. We analyzed the data from the prospective survey of Japanese primary myelofibrosis patients which was conducted from 1999 to clarify the impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis. A total of 202 primary myelofibrosis patients had the cytogenetic and the prognostic data. Eighty (40{\%}) out of 202 cases had cytogenetic abnormalities, and an association was evident for platelet counts. Although the presence of an abnormal karyotype did not affect the prognosis, primary myelofibrosis patients with cytogenetic abnormalities other than 13q- and 20q- showed an inferior prognosis compared to patients with a normal karyotype or sole 13q- or 20q- abnormalities. Patients with an unfavorable cytogenetic profile (abnormal cytogenetics other than 13q- or 20q-) also had a greater tendency to transform to leukemia than patients with a favorable cytogenetic profile (normal cytogenetics, sole abnormalities of either chromosome 13q-, or 20q-). Abnormal cytogenetics other than 13q- or 20q- in primary myelofibrosis patients has the poor prognostic effect for both survival and the risk of leukemic transformation.",
author = "Tomonori Hidaka and Kotaro Shide and Haruko Shimoda and Takurou Kameda and Keiko Toyama and Keiko Katayose and Youko Kubuki and Kenji Nagata and Katsuto Takenaka and Koichi Akashi and Takashi Okamura and Yoshiyuki Niho and Hideaki Mizoguchi and Mitsuhiro Omine and Keiya Ozawa and Mine Harada and Kazuya Shimoda",
year = "2009",
month = "10",
day = "1",
doi = "10.1111/j.1600-0609.2009.01298.x",
language = "English",
volume = "83",
pages = "328--333",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis

T2 - A prospective survey of 202 cases in Japan

AU - Hidaka, Tomonori

AU - Shide, Kotaro

AU - Shimoda, Haruko

AU - Kameda, Takurou

AU - Toyama, Keiko

AU - Katayose, Keiko

AU - Kubuki, Youko

AU - Nagata, Kenji

AU - Takenaka, Katsuto

AU - Akashi, Koichi

AU - Okamura, Takashi

AU - Niho, Yoshiyuki

AU - Mizoguchi, Hideaki

AU - Omine, Mitsuhiro

AU - Ozawa, Keiya

AU - Harada, Mine

AU - Shimoda, Kazuya

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Cytogenetic abnormalities were often observed in primary myelofibrosis patients. The presence of specific cytogenetic abnormalities, such as sole abnormalities of chromosome 13q-, 20q-, or -7/7q-, is reported to have the influence on the prognosis of primary myelofibrosis. We analyzed the data from the prospective survey of Japanese primary myelofibrosis patients which was conducted from 1999 to clarify the impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis. A total of 202 primary myelofibrosis patients had the cytogenetic and the prognostic data. Eighty (40%) out of 202 cases had cytogenetic abnormalities, and an association was evident for platelet counts. Although the presence of an abnormal karyotype did not affect the prognosis, primary myelofibrosis patients with cytogenetic abnormalities other than 13q- and 20q- showed an inferior prognosis compared to patients with a normal karyotype or sole 13q- or 20q- abnormalities. Patients with an unfavorable cytogenetic profile (abnormal cytogenetics other than 13q- or 20q-) also had a greater tendency to transform to leukemia than patients with a favorable cytogenetic profile (normal cytogenetics, sole abnormalities of either chromosome 13q-, or 20q-). Abnormal cytogenetics other than 13q- or 20q- in primary myelofibrosis patients has the poor prognostic effect for both survival and the risk of leukemic transformation.

AB - Cytogenetic abnormalities were often observed in primary myelofibrosis patients. The presence of specific cytogenetic abnormalities, such as sole abnormalities of chromosome 13q-, 20q-, or -7/7q-, is reported to have the influence on the prognosis of primary myelofibrosis. We analyzed the data from the prospective survey of Japanese primary myelofibrosis patients which was conducted from 1999 to clarify the impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis. A total of 202 primary myelofibrosis patients had the cytogenetic and the prognostic data. Eighty (40%) out of 202 cases had cytogenetic abnormalities, and an association was evident for platelet counts. Although the presence of an abnormal karyotype did not affect the prognosis, primary myelofibrosis patients with cytogenetic abnormalities other than 13q- and 20q- showed an inferior prognosis compared to patients with a normal karyotype or sole 13q- or 20q- abnormalities. Patients with an unfavorable cytogenetic profile (abnormal cytogenetics other than 13q- or 20q-) also had a greater tendency to transform to leukemia than patients with a favorable cytogenetic profile (normal cytogenetics, sole abnormalities of either chromosome 13q-, or 20q-). Abnormal cytogenetics other than 13q- or 20q- in primary myelofibrosis patients has the poor prognostic effect for both survival and the risk of leukemic transformation.

UR - http://www.scopus.com/inward/record.url?scp=70349158376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349158376&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2009.01298.x

DO - 10.1111/j.1600-0609.2009.01298.x

M3 - Article

C2 - 19549278

AN - SCOPUS:70349158376

VL - 83

SP - 328

EP - 333

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 4

ER -